NCT01549119View on ClinicalTrials.gov

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

December 31, 2014

Conditions
HIV-1 Infection
Interventions
BIOLOGICAL

VAC-3S

Comparison of different doses of vaccine. Liquid form Volume: 0.5 mL - 2 X 0.5 mL for double-dose arm 3 vaccinations at one month apart

BIOLOGICAL

Placebo

Comparison with experimental vaccine

Trial Locations (2)

75013

Hopital Pitie Salpetriere, Paris

75014

CIC Cochin Pasteur, Paris

Sponsors

Lead Sponsor

InnaVirVax
All Listed Sponsors
lead

InnaVirVax

INDUSTRY